GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Biora Therapeutics
Biora is a biotech company developing innovative systems for intestinal drug delivery and diagnostics. Its stock price represents a venture capital bet on the success of its technology, but for now, it's a story that requires significant funding.
Share prices of companies in the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including a smart capsule for the oral administration of biologics. We've categorized it under "Pharma: Gastrointestinal." The chart below shows how the market values companies solving the problem of complex drug delivery.
Broad Market Index - GURU.Markets
Biora Therapeutics is a biopharmaceutical company developing innovative systems for oral drug delivery and gastrointestinal diagnostics. As a component of the GURU.Markets index, it represents the biotech sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
BIOR - Daily change in the company's share price Biora Therapeutics
For Biora Therapeutics, Inc., a developer of drug delivery systems, daily volatility reflects sensitivity to clinical trial data. This metric is key for assessing risks in this innovative field.
Daily change in the price of a set of shares in a market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral biologics, for the treatment of gastrointestinal diseases. This is at the forefront of biotechnology. The chart below illustrates the volatility in this sector, reflecting the risks and potential associated with BIOR's developments.
Daily change in the price of a broad market stock, index - GURU.Markets
Biora Therapeutics develops ingestible devices for drug delivery and diagnostics of gastrointestinal diseases. This revolutionary company's stock reflects both the high hopes and risks associated with the future of medicine, and its high volatility impacts the entire market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Biora Therapeutics
Biora Therapeutics' year-over-year performance is a story of its innovative drug delivery and diagnostic platforms. Its 12-month market cap is entirely dependent on clinical trial data. The success of its "smart" pill for delivering biologics to the intestines could be a breakthrough in the treatment of inflammatory diseases.
Annual dynamics of market capitalization of the market segment - Pharma git
Biora Therapeutics develops innovative systems for drug delivery to the gastrointestinal tract. Its stock price is extremely volatile, reflecting investor confidence in its breakthrough scientific potential and ability to commercialize its unique platform, rather than its current financial performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biora Therapeutics, a company developing smart capsules for delivering drugs directly to the intestines and gastrointestinal monitoring systems, is at the intersection of pharmacology and technology. Its annual market capitalization growth reflects its bet on revolutionizing the treatment and diagnosis of gastrointestinal diseases.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems. Being in the clinical stage, its monthly evaluation is entirely dependent on news. Trial results confirming the viability of its unique technology are the primary driver.
Monthly dynamics of market capitalization of the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including smart capsules for the oral administration of biologics. This sector is at the intersection of pharmaceuticals and engineering. The chart below reflects how investors assessed the prospects of these revolutionary, yet risky, technologies that could change the way we treat patients.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Biora Therapeutics develops innovative drug delivery methods, including smart capsules. It's a biotech company at the intersection of engineering and biotechnology. Its stock price depends on the success of clinical trials for its unique platform, not on general market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Biora Therapeutics
Shares of Biora Therapeutics, which develops smart pills for diagnostics and drug delivery, are extremely volatile. Weekly price movements depend entirely on news about the progress of clinical trials of their innovative technology. The chart below illustrates how short-term scientific developments and investor expectations shape biotech valuations.
Weekly dynamics of market capitalization of the market segment - Pharma git
Biora Therapeutics is developing innovative drug delivery methods, including "smart" pills. This could revolutionize the treatment of many diseases. The chart below shows how expectations for this futuristic technology are impacting the company's stock, making it highly volatile.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Biora Therapeutics is a biotech company. This chart shows how its weekly performance, like that of other biotechs, is detached from the market. Its stock price movements are driven by clinical trial news and regulatory decisions, not macroeconomic data.
Market capitalization of the company, segment and market as a whole
BIOR - Market capitalization of the company Biora Therapeutics
Biora Therapeutics' valuation on the chart reflects its new strategy, which focuses on developing "smart" pills for drug delivery directly to the gut and diagnostics. Its market cap reflects investors' faith in the potential of this futuristic technology after the failure of its previous diagnostic tests.
BIOR - Share of the company's market capitalization Biora Therapeutics within the market segment - Pharma git
Biora Therapeutics' market share in the pharmaceutical industry reflects its focus on innovative drug delivery methods. Its market share is based on its technologies, such as smart capsules for targeted intestinal delivery and devices for painless administration of biologics.
Market capitalization of the market segment - Pharma git
The chart shows the total market capitalization of biotech companies developing oral drug delivery systems. Biora Therapeutics is one of the players in this field. The graph shows how the market values technologies that could replace injections with tablets for the treatment of complex diseases.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart visualizes the market value of a "smart" pill. Biora Therapeutics' market cap is based on its technology for delivering drugs directly to the intestines. The line shows how this breakthrough idea, which could change the treatment of many diseases, is competing for its share of the global pharmaceutical market.
Book value capitalization of the company, segment and market as a whole
BIOR - Book value capitalization of the company Biora Therapeutics
Biora Therapeutics' book value represents its scientific capital. The chart below reflects the valuation of its development pipeline, including a smart capsule for intestinal drug delivery and diagnostic technologies. The pipeline's growth reflects success in clinical trials, the company's primary asset.
BIOR - Share of the company's book capitalization Biora Therapeutics within the market segment - Pharma git
Biora Therapeutics's core assets are its R&D centers and manufacturing facilities for developing innovative drug delivery systems in the form of swallowable capsules. The chart shows the company's share of this unique medical infrastructure, which has the potential to transform the treatment of gastrointestinal diseases.
Market segment balance sheet capitalization - Pharma git
Biotechnology is a world of contrasts. The graph shows the massive factories of pharmaceutical giants. Biora Therapeutics, as a development company, has a more streamlined model. Its value lies in its intellectual property, not in the scale of production that is typical of the R&D stage.
Book value of all companies included in the broad market index - GURU.Markets
Biora Therapeutics develops innovative drug delivery methods, including a "smart" capsule for the oral delivery of biologics. The company's assets aren't factories, but rather unique technology at the intersection of medicine and engineering. The graph shows the material weight behind this "drone pill."
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Biora Therapeutics
Biora Therapeutics develops innovative drug delivery methods, including smart capsules. Its value lies in its unique technological platform. The chart below visualizes its bet on the future of pharmaceuticals. The market valuation reflects the technology's potential, not the value of its current assets.
Market to book capitalization ratio in a market segment - Pharma git
Biora Therapeutics, Inc. develops innovative gastrointestinal drug delivery systems. Its value lies in this unique platform. This chart shows how its market valuation, based on the potential of its technology, compares to its tangible assets.
Market to book capitalization ratio for the market as a whole
Biora Therapeutics develops innovative drug delivery systems, including a smart capsule for the oral administration of biologics. The market valuation, shown in this chart, is based on the potential of their breakthrough technology to replace injections.
Debts of the company, segment and market as a whole
BIOR - Company debts Biora Therapeutics
Biora Therapeutics, a company developing innovative drug delivery systems (such as smart capsules), uses raised capital to fund its R&D programs. This chart shows how the company spends funds on the development and clinical trials of its futuristic technologies.
Market segment debts - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for intestinal delivery of biologics. This chart shows how its leverage reflects the high risk and capital intensity of its research, funded primarily by equity while its technology is in the clinical stage.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Biora Therapeutics
Blade Air Mobility provides urban air mobility services using helicopters and, in the future, eVTOLs. This is a business that requires access to expensive assets. The chart shows how the company finances its operations, betting that affluent clients are willing to pay for time savings.
Market segment debt to market segment book capitalization - Pharma git
Biora Therapeutics is a biotech company developing systems for oral drug delivery and diagnostics for gastrointestinal diseases. This chart compares its debt load to the overall market capitalization of the pharmaceutical sector. It shows how the company finances its innovative platforms.
Debt to book value of all companies in the market
Biora Therapeutics develops innovative drug delivery methods, such as smart capsules for orally administered biologics. This could revolutionize the treatment of many diseases. This chart of total market debt shows the overall risk appetite, which is important for a company raising capital for its breakthrough but risky R&D projects.
P/E of the company, segment and market as a whole
P/E - Biora Therapeutics
For Biora Therapeutics, a biopharmaceutical company developing drug delivery systems, the P/E ratio is not applicable. The company has no profit. Its valuation is based on its innovative technologies, such as capsules for oral delivery of biologics, and success in clinical trials.
P/E of the market segment - Pharma git
Biora Therapeutics is a biotech company developing innovative systems for oral drug delivery and diagnostics of gastrointestinal diseases. Their goal is to replace injections and invasive procedures with pills. This chart shows the average valuation for the pharmaceutical sector, reflecting how investors value breakthrough drug delivery technologies.
P/E of the market as a whole
Biora Therapeutics develops innovative drug delivery systems, including a ingestible capsule for delivering biologics directly to the intestines and diagnostic devices. This risk appetite chart helps understand how investors value companies working on breakthrough drug delivery technologies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for administering biologics. This chart reflects investors' confidence in the potential of this technology to replace injections. Future profits depend on the success of clinical trials.
%20P%2FE%20Biora%20Therapeutics&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Biora-Therapeutics&v=1772629718354 "Chart of the company's future (projected) P/E Biora Therapeutics")
Future (projected) P/E of the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for intestinal delivery of biologics. This chart reflects investor sentiment for its breakthrough technology platform. It compares expectations for Biora with other companies working on new drug delivery methods.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-git&v=1772629718365 "Future (projected) P/E graph of the market segment - Pharma git")
Future (projected) P/E of the market as a whole
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for intestinal delivery of biologics. The company's success depends on clinical trial results. The overall market optimism demonstrated by this chart is important for attracting the capital needed to advance such breakthrough medical technologies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772629718377 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for intestinal delivery of biologics. Being in the clinical stage, the company incurs significant R&D expenditures. This chart illustrates the financial trajectory of a biotech company seeking to solve one of the key challenges in pharmaceuticals.
Profit of companies in the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for intestinal delivery of biologics. This graph, showing overall sector profitability, reflects the search for alternatives to injections. Success with Biora's technology could revolutionize the treatment of many diseases and fundamentally change the pharmaceutical market.
Overall market profit
Biora Therapeutics is developing innovative drug delivery systems, including oral capsules for administering biologic drugs that currently require injections. This could revolutionize the treatment of many chronic diseases.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for targeted gastrointestinal therapy. Revenue projections are speculative and depend on the success of its clinical programs.
%20profit%20of%20the%20company%20Biora%20Therapeutics&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Biora-Therapeutics&v=1772629718450 "Graph of future (projected) profit of the company Biora Therapeutics")
Future (predicted) profit of companies in the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for biologics and diagnostic devices. This chart shows revenue forecasts for the entire pharmaceutical sector. It helps assess how the company's breakthrough technology could change the market and how this compares to overall expectations.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-git&v=1772629718469 "Graph of future (predicted) profits of companies in a market segment - Pharma git")
Future (predicted) profit of the market as a whole
Biora Therapeutics develops innovative drug delivery systems, such as oral capsules for administering biologics. This is a breakthrough technology. This chart, reflecting investor sentiment, is important for Biora. During periods of market optimism, companies working to change the paradigm in medicine find it easier to raise capital for their research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772629718483 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for delivering biologics to the intestines. This metric, which correlates market capitalization with minimum revenue, reflects pure potential. It demonstrates investor confidence in its breakthrough technology, which could replace injections with pills.
P/S market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for delivering biologics to the gastrointestinal tract and diagnostic devices for monitoring gastrointestinal health. This chart reflects the market's willingness to pay for biotech revenue, demonstrating confidence in the breakthrough potential of Biora's technology platforms.
P/S of the market as a whole
Biora Therapeutics develops innovative systems for oral drug delivery and diagnostics of gastrointestinal diseases. This chart, reflecting the average valuation, shows that investors value the company based on the potential of its unique technology platforms.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems, including oral biologics and diagnostic devices. This chart shows the market's estimate of its potential future revenue. It reflects investor confidence in its technology and commercial potential should clinical trials be successful.
%20P%2FS%20Biora%20Therapeutics&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Biora-Therapeutics&v=1772629718628 "The graph of the company's future (projected) P/S Biora Therapeutics")
Future (projected) P/S of the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for intestinal delivery of biologics. The chart shows the average estimated future sales in the gastrointestinal diseases sector. It helps understand how investors view the breakthrough potential of Biora's technology and the associated risks of clinical development.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20git&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-git&v=1772629718661 "Future (projected) P/S market segment graph - Pharma git")
Future (projected) P/S of the market as a whole
Biora Therapeutics (BIOR) develops innovative drug delivery systems, such as smart capsules for the treatment of gastrointestinal diseases. Their future depends on the success of clinical trials. This timeline is unrelated to their mission to create new, more effective therapies.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772629718671 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Biora Therapeutics
Biora Therapeutics is a biotech company developing innovative drug delivery systems. Currently in the clinical stage, it has no sales revenue. It creates smart capsules for targeted therapies for gastrointestinal diseases. The graph reflects future revenue from licensing or partnerships based on its unique technology.
Sales of companies in the market segment - Pharma git
Biora Therapeutics (formerly Progenity) is a biotechnology company developing innovative drug delivery systems for the gastrointestinal tract. Following the sale of its diagnostics business, its future revenue will depend on the success of its technology platforms in partnerships with pharmaceutical companies.
Overall market sales
Biora Therapeutics, Inc. develops innovative drug delivery systems, such as oral biologics. As a clinical-stage company, its success depends on scientific breakthroughs. The overall economic environment, shown in this chart, influences the availability of venture capital and the interest of large pharmaceutical companies in partnerships to commercialize new drug delivery technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for biologics. Future revenue depends on the success of these technologies. This graph reflects long-term expectations for its development pipeline.
%20sales%20of%20the%20company%20Biora%20Therapeutics&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Biora-Therapeutics&v=1772629718725 "Schedule of future (projected) sales of the company Biora Therapeutics")
Future (projected) sales of companies in the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for delivering biologics to the intestines. This chart shows the outlook for the gastroenterology sector. It reflects the desire to replace injections with more convenient oral forms, which could revolutionize the treatment of inflammatory bowel diseases.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-git&v=1772629718730 "Schedule of future (projected) sales of companies in the market segment - Pharma git")
Future (projected) sales of the market as a whole
The biotech investment climate illustrated by this chart is important for Biora Therapeutics. The company develops innovative drug delivery systems and diagnostics for gastrointestinal diseases. Funding for its research and product launches is directly dependent on capital inflows into the sector.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772629718763 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems, such as capsules for the oral administration of biologics. This graph reflects the research and development stage. Future profitability depends on the success of clinical trials and partnerships with pharmaceutical companies to commercialize its technologies.
Market segment marginality - Pharma git
Biora Therapeutics is a biopharmaceutical company developing innovative drug delivery systems for the gastrointestinal tract. Profitability depends on the success of its technology platform. This chart shows the average profitability in the pharmaceutical industry. It provides context for assessing the potential of its unique approaches to treating gastrointestinal diseases.
Market marginality as a whole
Biora Therapeutics develops innovative drug delivery systems, such as oral capsules for biologics. As a research-stage company, it relies on funding and partnerships. This chart reflects the overall investment climate, which determines whether investors and large pharmaceutical companies are willing to invest in breakthrough but risky technologies.
Employees in the company, segment and market as a whole
Number of employees in the company Biora Therapeutics
Biora Therapeutics develops innovative drug delivery systems, such as capsules for the oral administration of biologics. This graph depicts the team of scientists and engineers. The dynamics show how the company is focusing its resources on the development and clinical trials of its unique technology, which has the potential to transform the treatment of many diseases.
Share of the company's employees Biora Therapeutics within the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including a smart capsule for oral delivery of biologics and diagnostic devices. This chart shows the company's share of the total number of scientists in this cutting-edge field, reflecting its technological potential.
Number of employees in the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for delivering biologics to the intestines. This chart, showing employment in the gastrointestinal pharmaceutical sector, is important. The growing number of scientists in this field indicates the search for alternatives to injections for the treatment of chronic inflammatory bowel diseases.
Number of employees in the market as a whole
Biora Therapeutics develops innovative drug delivery methods, including smart pills. This overall employment chart reflects the state of the biotech sector, which is dependent on investment. The economic growth shown here creates a favorable environment for funding companies working on breakthrough pharmaceutical technologies.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Biora Therapeutics (BIOR)
Biora Therapeutics (BIOR) is a biotechnology company developing drug delivery systems (e.g., smart capsules for the gastrointestinal tract) and diagnostics. Their value lies in their intellectual capital (device patents). This metric reflects the high valuation of their engineering and biotechnological developments.
%20of%20the%20company%20Biora%20Therapeutics%20(BIOR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Biora-Therapeutics-BIOR&v=1772629719004 "Chart of market capitalization per employee (in thousands of dollars) of the company Biora Therapeutics (BIOR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, such as "smart" capsules for the treatment of gastrointestinal diseases. It combines pharmaceuticals and engineering. This graph illustrates the market potential for a breakthrough technology developed by a relatively small but multidisciplinary team.
%20by%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-git&v=1772629719018 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma git")
Market capitalization per employee (in thousands of dollars) for the overall market
Biora Therapeutics develops innovative drug delivery systems, such as oral capsules for administering biologics. The company's market capitalization is based on its unique technological platform. This metric reflects the high value the market places on breakthrough technology created by a small team of scientists and engineers.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772629719023 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Biora Therapeutics (BIOR)
Biora Therapeutics (formerly Progenity) is a biotech company developing smart pills (capsules) for delivering drugs directly to the intestines, as well as diagnostic systems. This is R&D. This chart shows the company's "burn rate": how much the company spends (negative profit) on each scientist to create these futuristic technologies.
%20Chart%20Biora%20Therapeutics%20(BIOR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Biora-Therapeutics-BIOR&v=1772629719031 "Company Profit Per Employee (in thousands of dollars) Chart Biora Therapeutics (BIOR)")
Profit per employee (in thousands of dollars) in the market segment - Pharma git
Biora Therapeutics develops innovative drug delivery systems, including oral capsules for intestinal delivery of biologics. For a development-stage biotech company, this chart reflects the effectiveness of R&D management. The potential for growth in this metric is enormous if their platform technology is successful.
%20in%20the%20market%20segment%20-%20Pharma%20git&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-git&v=1772629719041 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma git")
Profit per employee (in thousands of dollars) for the market as a whole
Biora Therapeutics (BIOR) (formerly Progenity) is a biotechnology company developing intestinal drug delivery technologies (tablets) and monitoring systems. It is an R&D company. There is no profit. This metric is negative and reflects the "cost" of one scientist/engineer.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772629719061 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Biora Therapeutics (BIOR)
Biora Therapeutics develops innovative drug delivery systems, including smart pills. Revenue may be minimal during the clinical development stage. This graph is important as an indicator of potential: a successful technology could be licensed to major pharmaceutical companies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Biora-Therapeutics-BIOR&v=1772629719069 "Sales chart per company employee Biora Therapeutics (BIOR)")
Sales per employee in the market segment - Pharma git
Biora Therapeutics is a biotech R&D company developing smart pills for delivering drugs directly to the intestines (for example, to treat IBD). This chart reflects their R&D status. The productivity of their team of engineers and scientists lies in the creation of this futuristic delivery technology, not in current sales.
Sales per employee for the market as a whole
Cannae Holdings (CNL) is not an operating company, but a holding company managed by activist investor Bill Foley. Foley holds significant stakes in various companies, both public and private (for example, in fintech and restaurants). This chart shows the holding company's structure. Cannae has a very small staff managing these investments. Revenue (or changes in revenue) depends on the performance of its portfolio companies.
Short shares by company, segment and market as a whole
Shares shorted by company Biora Therapeutics (BIOR)
Biora Therapeutics (BIOR), formerly Progenity, is a company developing a "smart" pill for gastrointestinal drug delivery. This chart shows the volume of short positions. The shorts reflect the high skepticism surrounding this speculative technology and the failure of its previous products.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Biora-Therapeutics-BIOR&v=1772629719118 "Short Shares Chart for the Company Biora Therapeutics (BIOR)")
Shares shorted by market segment - Pharma git
Biora Therapeutics (BIOR) develops innovative drug delivery systems, including "smart" pills for targeted gastrointestinal therapy. The chart below shows a general short position on the biotech sector. It demonstrates the general investor skepticism regarding the success of risky clinical trials.
Shares shorted by the overall market
Biora Therapeutics is developing futuristic drug delivery systems (for example, a "smart" capsule). This is an R&D project. This chart illustrates the overall market pessimism. When investors are fearful, they don't want to fund "science fiction." They see a "cash burn" and sell off shares, not believing in commercial success.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Biora Therapeutics (BIOR)
Biora Therapeutics (BIOR) develops innovative drug delivery systems, including a smart capsule for the oral administration of biologics to the gastrointestinal tract. It's a cutting-edge biotech company. This oscillator measures the strength of speculative moves. It shows when stocks are "overheated" (above 70) on trial news or "oversold" (below 30) due to delays.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Biora-Therapeutics-BIOR&v=1772629719186 "RSI 14 indicator chart for the company's stock Biora Therapeutics (BIOR)")
RSI 14 Market Segment - Pharma git
Biora Therapeutics is a biotech company developing innovative drug delivery systems in the form of "smart" capsules for the treatment of gastrointestinal diseases (such as ulcerative colitis). This chart measures the overall momentum in the gastrointestinal biotech sector and helps determine whether the entire speculative segment is overheated.
RSI 14 for the overall market
For Biora Therapeutics, a biotech in R&D, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BIOR (Biora Therapeutics)
Biora Therapeutics develops innovative drug delivery systems, including a "smart" capsule (Smart-Pill) that delivers drugs directly to the gastrointestinal tract. This chart shows the analysts' average 12-month forecast, representing their collective speculative bet on the success of this R&D platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BIOR-Biora-Therapeutics&v=1772629719231 "A chart showing analyst consensus forecasts for the expected stock price. BIOR (Biora Therapeutics)")
The difference between the consensus estimate and the actual stock price BIOR (Biora Therapeutics)
Biora (BIOR) is the stuff of medical sci-fi. The company develops "smart pills" (DDS)—miniature devices that deliver medication directly to the gastrointestinal tract or perform biopsies from within. This chart shows how far the current share price differs from its "fair" value. It reflects analysts' views on this futuristic, yet highly risky, R&D platform.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BIOR-Biora-Therapeutics&v=1772629719283 "A chart showing the difference between the consensus forecast and the actual stock price. BIOR (Biora Therapeutics)")
Analyst consensus forecast for stock prices by market segment - Pharma git
Biora (BIOR) is a biotech company developing "smart pills" that deliver drugs directly to the intestines or perform biopsies without endoscopy. This chart shows general expectations for the gastrointestinal pharmaceutical sector, reflecting experts' confidence in this futuristic R&D platform.
Analysts' consensus forecast for the overall market share price
Biora Therapeutics (BIOR) is a "smart pill." They develop capsules that patients swallow, which either take a "biopsy" of their intestines or inject the drug directly into their gut. This chart shows the overall risk appetite. It reflects the market's willingness to fund breakthrough, but extremely risky, R&D projects.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Biora Therapeutics
Biora (formerly Progenity) is a fantastic R&D company. Their signature feature is a smart pill: a swallowable robot capsule that is designed to automatically (without a needle) inject biologics (like Humira) directly into the intestinal wall (for gastrointestinal treatment). This chart is a clear indicator of faith in their (very futuristic) R&D and their (very risky) path to FDA approval.
AKIMA Market Segment Index - Pharma git
Biora Therapeutics is a biotech company focused on the gastrointestinal tract. They are developing smart capsules that can not only deliver drugs precisely to the intestines but also collect samples for diagnostics. This graph compares their composite index to the sector, showing how their smart pill compares to others.
The AKIM Index for the overall market
Biora Therapeutics is a biotech company developing "smart pills" for delivering drugs to specific parts of the intestine (IBD) and systemically. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this delivery technology platform compares to overall economic trends.
